Search | GSK

Patrick Vallance Presentation Transcript

https://www.gsk.com/media/8171/patrick-vallance-presentation-transcript.pdf

First published: 06 June 2022

https://www.gsk.com/media/11883/viiv-croi-curtain-raiser.pdf

First published: 09 March 2025

https://www.gsk.com/media/11771/fy-2024-pipeline-assets-and-clinical-trials-report.pdf

First published: 05 February 2025

https://www.gsk.com/media/8120/gsk-viiv-healthcare-ir-call-30-april-2019.pdf

First published: 01 June 2022

https://www.gsk.com/media/11972/q1-2025-results-transcript.pdf

First published: 01 May 2025

https://www.gsk.com/media/11962/q1-2025-results-announcement.pdf

First published: 30 April 2025

https://www.gsk.com/media/11859/strategic-report-2024.pdf

First published: 27 February 2025

https://www.gsk.com/media/11850/annual-report-2024.pdf

First published: 27 February 2025

https://www.gsk.com/media/11872/2024-annual-report-on-form-20-f.pdf

First published: 03 March 2025

Data from the BANNER study show antiviral efficacy, safety, and tolerability of N6LS, supporting its continued study in phase IIb

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-positive-proof-of-concept-findings-for-n6ls/

First published: 25 October 2022